Industry News
A "Life-And-Death" Molecule Identified On Chronic Leukemia Cells
Jun 01, 2012
A new study has identified a life-and-death signaling role for a molecule on the surface of the immune cells involved in the most common form of chronic leukemia. The finding could lead to more effective therapy for chronic lymphocytic leukemia (CLL), an as yet incurable cancer that occurs in more than 16,000 Americans annually... Read More
Younger Colon Cancer Patients Have Worse Prognosis At Diagnosis, Yet Better Survival
Jun 01, 2012
Younger patients with colorectal cancer were more likely to present advanced stage tumors at diagnosis and metastasize much sooner, yet had better than or equal survival to patients 50 and older, according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. (Abstract #3621, Monday, June 4, 8:00 AM - 12:00 PM CST, S Hall A2)... Read More
Researcher Develops New Antibodies To Target And Destroy Cancer Cells
Jun 01, 2012
Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price - many healthy cells essential for body functions are also targeted and killed by the toxin. This dangerous side-effect has prompted researchers to seek better and more selective ways to kill cancer cells inside the body. Prof... Read More
Diagnostic Biochip-Based Device Can Detect Leukemia, HIV
Jun 01, 2012
Inexpensive, portable devices that can rapidly screen cells for leukemia or HIV may soon be possible thanks to a chip that can produce three-dimensional focusing of a stream of cells, according to researchers. "HIV is diagnosed based on counting CD4 cells," said Tony Jun Huang, associate professor of engineering science and mechanics, Penn State... Read More
Diagnostic Biochip-Based Device Can Detect Leukemia, HIV
Jun 01, 2012
Inexpensive, portable devices that can rapidly screen cells for leukemia or HIV may soon be possible thanks to a chip that can produce three-dimensional focusing of a stream of cells, according to researchers. "HIV is diagnosed based on counting CD4 cells," said Tony Jun Huang, associate professor of engineering science and mechanics, Penn State... Read More
Diabetes Drug Pioglitazone Associated With Bladder Cancer Risk
Jun 01, 2012
According to a study published in British Medical Journal (BMJ), a drug for treating type 2 diabetes called Pioglitazone is linked to a higher risk of bladder cancer and taking the drug continuously for longer than two years doubles the risk. The researchers stress, however, that the risk in absolute terms is relatively low with up to 137 extra cases per 100,000 person years... Read More
Diabetes Drug Pioglitazone Associated With Bladder Cancer Risk
Jun 01, 2012
According to a study published in British Medical Journal (BMJ), a drug for treating type 2 diabetes called Pioglitazone is linked to a higher risk of bladder cancer and taking the drug continuously for longer than two years doubles the risk. The researchers stress, however, that the risk in absolute terms is relatively low with up to 137 extra cases per 100,000 person years... Read More
Study Compares The Epigenetic Markers Of A Healthy Person And One With A Genetic Disease
Jun 01, 2012
A study led by Manel Esteller, director of the Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), professor of genetics at the University of Barcelona and ICREA researcher has completed the first epigenome in Europe. The finding is published in the international scientific journal Epigenetics... Read More
After Cancer Diagnosis, Men And Women Receive Different Fertility Advice
Jun 01, 2012
There are significant gaps in the information women receive about their future fertility following cancer diagnosis, suggests a new paper published in BJOG: An International Journal of Obstetrics and Gynaecology. Infertility can be a side-effect of cancer treatment and there are increasing numbers of people of reproductive age undergoing such treatment... Read More
Breast Stem-Cell Research Reveals Receptor Teamwork Required, Possible Involvement Of New Pathway
Jun 01, 2012
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells. Mammary stem cells produce various kinds of breast cell types. They may also drive the development and growth of malignant breast tumors... Read More
Previous Page Next Page